Omeros Stock

Omeros Current Assets

The Current Assets of Omeros (OMER) as of Aug 4, 2026 is 179.40 M USD. In the previous year, Current Assets was 134.12 M USD — a change of 33.76% (higher).

Current Assets

179.40 MUSD

YoY

33.76%

Last updated:

Current Assets of Omeros is 2026 179.40 M USD. Current Assets of Omeros was 2025 134.12 M USD. It decreases by 33.76% higher compared to the previous year.
Access this data via the Eulerpool API

Omeros Stock analysis

What does Omeros do? Omeros Corp is a biopharmaceutical company based in Seattle, Washington, that focuses on the discovery, development, and commercialization of innovative therapies. The company has developed a wide range of products and technologies in various areas of the medical sector, including ophthalmology, immunology, oncology, and neurology. Omeros is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Omeros stock

Current Assets of Omeros is 179.40 M USD in 2026.

Current Assets of Omeros changed from 134.12 M USD to 179.40 M USD, representing a 33.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Omeros since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Omeros historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Omeros

All Key Metrics — Omeros